GRI Bio, Inc. Reports Change in Certifying Accountant
Ticker: GRI · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1824293
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
GRI Bio swapped accountants, filing 8-K on 4/16/25.
AI Summary
GRI Bio, Inc. filed an 8-K on April 16, 2025, reporting changes in its certifying accountant as of April 15, 2025. The company, formerly known as Vallon Pharmaceuticals, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
A change in a company's auditor can signal shifts in financial reporting scrutiny or internal control assessments.
Risk Assessment
Risk Level: low — This filing is a routine administrative update regarding the company's auditor and does not involve significant financial or operational changes.
Key Players & Entities
- GRI Bio, Inc. (company) — Registrant
- Vallon Pharmaceuticals, Inc. (company) — Former company name
- 20250411 (date) — Date of earliest event reported
- 20250415 (date) — Date as of change
- 20250416 (date) — Filing date
FAQ
What is the primary reason for the 8-K filing by GRI Bio, Inc.?
The primary reason for the 8-K filing is to report a change in the registrant's certifying accountant.
When was the change in the certifying accountant effective?
The change in the certifying accountant was effective as of April 15, 2025.
What was GRI Bio, Inc. formerly known as?
GRI Bio, Inc. was formerly known as Vallon Pharmaceuticals, Inc.
In which state is GRI Bio, Inc. incorporated?
GRI Bio, Inc. is incorporated in Delaware.
What is the business address of GRI Bio, Inc.?
The business address of GRI Bio, Inc. is 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding GRI Bio, Inc. (GRI).